| |
 |
|
| Access to medicine is a basic right, yet each year millions of people, the majority of whom live in developing countries, die of preventable and treatable diseases. Others suffer needlessly from chronic or neglected ailments that could be eliminated but remain untreated. In the near future, as the population of the developing world grows, the imbalance of medical supplies and access to healthcare will only be exacerbated. |
|
| At Dr. Reddy's, we believe that as a responsible global pharmaceutical company, we can contribute in more ways than one. |
|
| We are committed to bring down the cost of treatment through the development of a wide spectrum of generics. We focus specifically on drugs that affect a large section of the population and where the existing 'cost of cure' is high. We leverage our strong skills in complex chemistry to accelerate the development of such generics. We continuously invest in augmenting our research capabilities with a view to expand our generics portfolio. |
|
| It is our constant endeavour to enhance the reach of our affordable generics by making them available to as many people as we can. Towards this objective we regularly enlarge our footprint by entering new geographies and penetrate deeper in our existing markets. |
|
| Over and above access and affordability we also work towards enhancing the efficiency and efficacy of medicine. We do this by developing differentiated formulations that facilitate easy and calibrated dosages and enhance patient comfort. |
|
| We go beyond these core pharmaceutical responsibilities to help bridge primary gaps in health infrastructure and delivery systems, availability of healthcare personnel and access to diagnostics. We accomplish these goals by working hand in hand with our employees, supply chain partners and with the Dr. Reddy's Foundation. |
|
| |
| |
